[1, 2, 4]-oxadiazoles: Synthesis and biological applications

Mini-Reviews in Medicinal Chemistry

Volumn 14, Issue 4, 2014, Pages 355-369

  Bora, Rajesh O ^a   Dar, Bashir ^a,b   Pradhan, Vidya ^c   Farooqui, Mazahar ^a,c  

^a MAULANA AZAD COLLEGE   (India)

^b CSIR INDIAN INSTITUTE OF INTEGRATIVE MEDICINE   (India)

^c Dr Rafiq Zakaria College for Women ^*  (India)

Author keywords

Anaesthetic angent; Anti inflammatory; Anti tumor agents; Heterocycles; One pot synthesis; Synthetic methods; 1,2,4 oxadiazoles

Indexed keywords

1, 2, 4 OXADIAZOLE DERIVATIVE; 2, 5 BIS (4 AMIDINOPHENYL) FURAN; 3 [5 (2 FLUOROPHENYL) [ 1,2,4] OXADIAZOLE 3 YL] BENZOIC ACID; AMIDE; AMIDOXIME DERIVATIVE; ANTIHISTAMINIC AGENT; ANTITHROMBOCYTIC AGENT; BENZAMIDOXIME; DIMINAZENE ACETURATE; FURAZAN DERIVATIVE; HYPNOTIC AGENT; HYPOCHOLESTEROLEMIC AGENT; IMINOSUGAR; IMOLAMINE; ISRADIPINE; MOLSIDOMINE; NITRILE OXIDE; OXADIAZOLE DERIVATIVE; OXIME DERIVATIVE; OXOLAMINE CITRATE; PANADIPLON; PENTAMIDINE; PESTICIDE; PLECONARIL; RIBAVIRIN; SEDATIVE AGENT; SUMATRIPTAN; SYDNOCARB; TIAZOFURIN; UNCLASSIFIED DRUG; ZOPOLRESTAT; [1, 2, 3] OXADIAZOLE DERIVATIVE; [1,2,4] OXADIAZOLYLMETHYLENE AZABICYCLE;

ALZHEIMER DISEASE; ANTHELMINTIC ACTIVITY; ANTIARRHYTHMIC ACTIVITY; ANTIBACTERIAL ACTIVITY; ANTIHYPERTENSIVE ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; CLINICAL TRIAL (TOPIC); CYCLIZATION; CYCLOADDITION; DEHYDRATION; DIURETIC ACTIVITY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MICROWAVE RADIATION; MIGRAINE; NITROSATION; NONHUMAN; ONE POT SYNTHESIS; OXIDATION; PHASE 2 CLINICAL TRIAL (TOPIC); PYROLYSIS; REACTION ANALYSIS; RING CLOSING METATHESIS; SYNTHESIS;

ANESTHETICS; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOOD PLATELETS; FIBRINOLYTIC AGENTS; HYPERSENSITIVITY; OXADIAZOLES; PLATELET AGGREGATION INHIBITORS; VASODILATOR AGENTS; VENOUS THROMBOSIS;

EID: 84907858946     PISSN: 13895575     EISSN: 18755607     Source Type: Journal    
DOI: 10.2174/1389557514666140329200745     Document Type: Article

References (158)

1. Boyer, J. H. in: Heterocyclic Compounds, RC Elderfield. Ed.; John Wiley, New York, 1961, p. 425.
2. Kazitsyna, L. A.; Kikot, B. S. Quinone diazides and piminoquinone diazides. Russ. Chem. Res., 1966, 35, 388-405.
3. Majid, P. A.; Defeyter, P. J.; Van der Wall, E. E.; Wardeh F; Roos J. P. Molsidomine in the treatment of patients with angina pectoris: acute effects and clinical efficacy. N. Eng. J. Med., 1980, 302(1), 1-6.
4. Yashunskii, V. G.; Kholodov, L. E. The Chemistry of Sydnone Imines. Russ. Chem. Res., 1980, 49, 28-35.
5. Machula, A. I.; Barkor, N. K. Visual discrimination characteristics under the action of psychostimulants. Farma. Kol. Toksikol., 1980, 43, 16-21.
6. Cerecetto, H.; Porcal, W. Pharmacological properties of furoxans and benzofuroxans: recent developments. Mini-Rev. Med. Chem., 2005, 5(1), 57-71.
7. Hof, R. P.; Vogel, A. Drugs of the Future, 1988, 10, 746-747.
8. Visentin, S.; Amiel, P.; Fruttero, R.; Boschi, D.; Roussel, C.; Giusta, L.; Carbone, E.; Gasco, A. Synthesis and Voltage-Clamp Studies of Methyl 1,4-Dihydro-2,6-dimethyl-5-nitro-4 (benzofurazanyl) pyridine-3-carboxylate Racemates and Enantiomers and of Their Benzofuroxanyl Analogues. J. Med. Chem., 1999, 42(8), 1422-1427.
9. Mortarini, C. R.; Gasco, V. Antimicrobial properties of some furazan and furoxan derivatives. Eur. J. Med. Chem.-Chim. Ther., 1980, 15, 485-487.
10. Yagil, G.The proton dissociation constant of pyrrole, indole and related compounds. Tetrahedron, 1967, 23(6), 2855-2861.
11. Khan, M.K.; Zia-Ullah K; Rani, M.; Perveen, S.; Haider, M.; Choudhary, M.I. Microwave-Assisted Synthesis of 2,5-Disubstituted-1,3,4-Oxadiazoles. Lett. Org. Chem., 2004, 1, 50-52.
12. Joseph, J. P.; Harry, L. Y. Preparation of 2-amino-5-aryl-1234-oxadiazoles. U.S. 3,141,022, 1961.
13. Hökfel, B.; Jönsson, A. Hypoglycemic Activity in Relation to Chemical Structure of Potential Oral Antidiabetic Substances. III. 2-Benzenesulfonamido-5-alkyl-1,3,4-thiadiazoles and -oxadiazoles J. Med. Chem., 1962, 5(2), 247-257.
14. Sumangala V. Boja P. Punith B. Chidananda N. Arul Moli T. Shalini S. Synthesis, characterization and antioxidant activity of some 1,3,4-oxadiazoles carrying 4-(methylsulfonyl)benzyl moiety. Der. Pharma. Chemica., 2011, 3(6), 138-146.
15. Anis, R.; Rafik, G.; Zine, M. Novel synthesis of 1,2,4-oxadiazoles by condensation of arylamidoximes with N-substituted iminoethers. Heter. Commun., 2004, 10(2-3), 151-156.
16. Obushak, N. D.; Pokhodylo, N. T.; Pidlypnyi, N. I.; Matiichuk, V. S. Synthesis of 1,2,4- and 1,3,4-Oxadiazoles from 1-Aryl-5-methyl-1H-1,2,3-triazole-4-carbonyl Chlorides. Russian J. Org. Chem., 2008, 44(10), 1522-1527.
17. Kishore V.; Kumar S.; Narain N.K.; Parmar S.S.; Stenberg V.I. Protection of carrageenin edema and trypsin hydrolysis of bovine serum albumin by naphthylthiosemicarbazides and their cyclized oxadiazoles. Pharmacology, 1976, 14(5), 390-396.
18. Kishore V.; Kumar S.; Parmar S.S.; Senberg V.I. Antiinflammatory and antiproteolytic properties of naphthlthiosemicarbazides and cyclized oxadiazoles.Res. Commun. Chem. Pathol. Pharmacol., 1975, 11(4), 581-94.
19. Sengupta, S.K.; Pandey, O.P.; Srivastava, B.K.; Sharma, V.K. Synthesis, structural and biochemical aspects of titanocene and zirconocene chelates of acetylferrocenyl thiosemicarbazones. Transit. Met. Chem., 1998, 23, 349-353.
20. Reddy, Y.D.; Somayajulu, V.V. Synthesis, spectra and physiological activity of 7-H-pyrano[3,2-c]benzoxazole-7-ones. J. Ind. Chem. Soc., 1981, 58, 599-601.
21. Kurzer, F. Thiadiazoles and selenadiazoles. Org. Compd. Sulphur, selenium, Tellurium. 1974, 4, 417-452.
22. Yale, H. L.; Losee, K. 2-Amino-5-substituted-l,3,4-oxadiazoles and 5-amino-2-substituted-l,3,4-oxadiazolines. A group of novel muscle relaxants. J. Med. Chem., 1966, 9, 478-483.
23. Yehya M.; Elkholy K.; Ali A.; Ahmad M. F. Convenient synthesis of some new substituted pyrazolyl-1,3,4-oxadiazoles and pyrazolyl-1,2,4-triazoles. J. Heter. Chem., 2006, 43(5), 1183-1188.
24. Hakko Chem. Ind. Co. Ltd., Brit. Pat. 1,266,542/1972; Chem. Abstr., 1972, 77, 5474g.
25. Yadav, L.D.S.; Singh, S.; Rai, V.K. A one-pot [Bmim]OH-mediated synthesis of 3-benzamidocoumarins. Tetrahedron Lett., 2009, 50, 2208-2212.
26. Masato, T.; Ko K. Jap. Pat., 772 508, 1977; Chem. Abstr., 1977, 87, 147054.
27. Ricardo A.W., Neves Filho and Rajendra M. Srivastava A Handy and Solventless Direct Route to Primary 3-[3-Aryl)-1,2,4-oxadiazol-5-yl]propionamides using microwave irradiation. Molecules, 2006, 11, 318-324.
28. Clapp, L.B. In "Advances in Heterocyclic Chemistry"; Katritzky, A.R., Ed.; Academic Press: New York, 1976, 20, 65-116.
29. Srivastava, R.M.; Morais, L.P.F.; Catanho, M.T.J.A.; Souza, G.M.L.; Seabra, G.M.; Simas, A.M.; Rodriguez, M.A.L. Synthesis and antiinflammatory activity of 3-aryl-5-isopropyl-1,2,4-oxadiazoles. Heterocycl. Commun., 2000, 6, 41-48.
30. Golie, L.; Leban I. Acta Crystallogr. Section B, 1979, 35(B), 2256-2258.
31. Clapp, L.B. In "Comprehensive Heterocyclic Chemistry"; Katritzky, A.R.; Rees, C.W., Eds.;Pergamon Press: Oxford, 1984, 6, 365-391.
32. Gangloff, A.R.; Litvak, J.; Shelton, E.J.; Sperandio, D.; Wang, V.R.; Rice, K.D. Synthesis of 3,5-disubstituted-1,2,4-oxadiazoles using tetrabutylammonium fluoride as a mild and efficient catalyst. Tetrahedron Lett., 2001, 42, 1441-1443.
33. Yale, H. C.; Spitzmiller, E.R. 3,5-Disubstituted-1,2,4-oxadiazoles and 4,5-dihydro-3,5-disubstituted-1,2,4-oxadiazoles J. Heterocycl. Chem., 1978, 15, 1373-1378.
34. Eloy, F.; Lenaers, R. The Chemistry of Amidoximes and Related Compounds. Chem. Rev., 1962, 62, 155-183.
35. Tiemann, F. Effect of Hydroxylamine on Nitriles. Chem. Ber., 1884, 17, 126-129.
36. Jochims, J.C. In "Comprehensive Heterocyclic Chemistry II"; Katritzky, A.R.; Rees, C.W.; Scriven, E.F.D., Eds.; Elsevier Science: Oxford, 1996, 4, 179-228.
37. LaMattina, J. L.; Mularski, C. J. Utility of p-Nitrophenyl. 3-Bromo-2,2-diethoXypropionate (NPBDP) in Heterocy- clic Synthesis. J. Org. Chem., 1984, 49, 4800-4805.
38. Amarsinghe, K. D.; Maier, M. B.; srivastava, A.; Gray, J. L. One-pot synthesis of 1,2,4-oxadiazoles from carboxylic acid esters and amidoximes using potassium carbonate. Tetrahedron Lett., 2006, 47, 3629-3631.
39. Steglich, W.; VanRee, T. Two Novel Syntheses of Substituted 1,2,4-Oxadiazoles from Amidoximes. Synth. Commun., 1982, 12, 457-461.
40. Chiou, S.; Shine, H.J. A simplified procedure for preparing 3,5-disubstituted-1,2,4-oxadiazoles by reaction of amidoximes with Acyl chlorides in pyridine solution. J. Heterocycl Chem., 1989, 26, 125-128.
41. Jack A.M.; Peter W.S.; Edward P.T.; William K.W. Some trans-phenylazo-1,2,4-oxadiazoles. J. Chem. Soc., Perkin Trans., 1974, 1, 81-85.
42. Kim, C. K.; Zielinski, P. A.; Maggiulli, C. A. A new synthetic route to 3-acylamino-1-aryl-2-pyrazolin-5-ones. J. Org. Chem., 1984, 49, 5247-5250.
43. Lin, Y.I.; Lang, S. A.; Lovell, Jr. M. F.; Perkinson, N. A. New synthesis of 1,2,4-triazoles and 1,2,4-oxadiazoles. J. Org. Chem., 1979, 44, 4160-4163.
44. Tilley, J. W.; Ramuz, H. The Synthesis of 3,5-Diamino-1,2,4-oxadiazoles. 1st Communication. Hel. Chim. Acta., 1980, 63, 832-840.
45. Tilley, J. W.; Ramuz, H. The Synthesis of 3,5-Diamino-1,2,4-oxadiazoles. 2nd Communication. Hel. Chim. Acta., 1980, 63, 841-845.
46. Demetrios, N. N.; Konstantinos, E. L.; Ioannis, V.; Konstantina, C. F. Thermal transformation of arylamidoximes in the presence of phosphorus ylides. Unexpected formation of 3-aryl-5-arylamino-1,2,4-oxadiazoles. J. Heter. Chem., 2004, 41, 499-503.
47. William, R. M.; Michael R. P. Thermal fragmentation of 1,2,5- and 1,2,4-oxadiazoles ARKIVOC, 2009, (14), 200-216.
48. Shahid, H.; Tashfeen, A. Recent Advances in the Synthesis of Five-Membered Heterocycles. Curr. Org. Chem., 2011, 15, 694-711.
49. Seeliger, W.; Aufderhaar, E.; Diepers, W.; Feinauer, R.; Nehring, R.; Thier, W.; Hellmann, H. Recent Syntheses and Reactions of Cyclic Imidic Esters. Angew. Chem., 1966, 5, 875-888.
50. Korzhavina, O. B.; Ryabukhin, Y. I.; Garnovskii, A. D.; Shavel, I. I. Synthesis of 4-oxo-1,3-benzothiazines and their salts. Chem. Heter. Comp., 1985, 21, 472-473.
51. Beckmann, Sandel Ann., 1897, 296, 285-290.
52. U. S. Pat. 2,648,669; Reaction product of sodium dicyanamide and hydroxylamine hydrochloride (OCR) C.A., 1953, 47, 11258.
53. Sharma, G. V. M.; Rakesh, B. A.; Krishna, P.R. Zirconium (IV) chloride mediated cyclodehydration of 1,2-diacylhydrazines: A convenient synthesis of 2,5-diaryl 1,3,4-oxadiazoles. Synth. Commun., 2004, 34, 2387-2391.
54. Li, Z.; Zhu, A.; Mao, X.; Sun, X.; Gong, X. Silica-supported dichlorophosphate: A recoverable cyclodehydrant for the eco-friendly synthesis of 2,5-disubstituted 1,3,4-oxadiazoles under solvent-free and microwave irradiation conditions. J. Braz. Chem. Soc., 2008, 19, 1622-1626.
55. Nagendra, G.; Lamani, R.S.; Narendra, N.; Sureshbabu, V.V. A convenient synthesis of 1,3,4-thiadiazole and 1,3,4-oxadiazole based peptidomimetics employing diacylhydrazines derived from amino acids. Tetrahedron Lett., 2010, 51, 6338-6341.
56. Conley T.; Mikulski, F.A. Abnormal Beckmann Rearrangements in Polyphosphoric Acid. I. Benzil Monoxime and Related Oximes J. Org. Chem., 1959, 24, 97-100.
57. Grundmann, C.; Grunanger, P. The Nitrile Oxides. Springer. Verley, 1971, 44.
58. Corsaro, A.; Chiacchio, U. The reaction of para-substituted β-aminocinnamonitriles with benzonitrile oxides J. Chem. Soc. Perkin-Trans., 1980, 1, 1635-1637.
59. Guan, M.; Bian, Z.Q.; Zhou, Y.F.; Li, F.Y.; Li, Z.J.; Huang, C.H. High-performance blue electroluminescent devices based on 2-(4-biphenylyl)-5-(4-carbazole-9-yl)phenyl-1,3,4- oxadiazole. Chem. Commun., 2003, 2003, 2708-2709.
60. Neidlein, R.; Li, S. Syntheses of 1,2,4-oxadiazole substituted pyrazole, isoxazole and pyrimidine heterocycles. J. Heterocycl. Chem., 1996, 33, 1943-1946.
61. Babak, K.; Fariba, S. Novel method for the synthesis of 1,2,4-oxadiazoles using alumina supported ammonium fluoride under solvent-free condition. J. Heter. Chem., 2005, 42(4), 699-701.
62. Savarino, A. A Historical sketch of the discovery and development of HIV-1 integrase inhibitors. Expert Opin. Investig. Drugs., 2006, 15, 1507-1522.
63. Katritzky, A.R.; Vvedensky, V.; Cai, X.; Rogovoy, B.; Steel, P.J. Synthesis of 5-(2-arylazenyl)- 1,2,4-triazoles and 2-amino-5-aryl-1,3,4-oxadiazoles. ARKIVOC, 2002, 6, 82-90.
64. Andrianov, V. G.; Eremeev, A. V. Synthesis of furazans by rearrangement of 3-acyl-1-oxa-2-azole oximes (review) Chemistry of Heterocyclic Compounds. 1990, 26, 1199-1213
65. Gupta, V.; Kashaw, S. K.; Jatav, V.; Mishra, P. Synthesis and antimicrobial activity of some new 3-[5-(4-substituted) phenyl-1,3,4-oxadiazole-2yl]-2-styrylquinazoline-4(3H)-ones. Med. Chem. Res., 2008, 17, 205-211.
66. Kenley, R. A.; Bedford, C. D.; Dailey, O. D.; Howd, R. A.; Miller, A. Nonquaternary cholinesterase reactivators. 2. Alpha-heteroaromatic aldoximes and thiohydroximates as reactivators of ethyl methylphosphonyl-acetylcholinesterase in vitro. J. Med. Chem., 1984, 27, 1201-1211.
67. Borg, S.; Luthman, K. 1,2,4-Oxadiazole derivatives of phenylalanine: potential inhibitors of substance P endopeptidase Eur. J. Med. Chem., 1993, 28, 801-805.
68. Crovetti, A. J.; Von Esch, A. M.; Thill, R. J. Halomethyl-1,2,4-oxadiazoles. I. Reactions employing 5-chloromethyl-3-(5-nitro-2-furyl)-1,2,4-oxadiazole. J. Heterocycl. Chem., 1972, 9, 435-442.
69. Kmetic, M.; Stanovnik, B. Nitrosation of methyl 2-cinnamoylamino-3-dimethylaminopropenoates. Alkyl N-cinnamoyloxalic acid hydroxyimidic amides, intermediates in the synthesis of alkyl 5-styryl-1,2,4-oxadiazole-3-carboxylates. J. Heterocycl. Chem., 1997, 34, 1705-1711.
70. Breuer, H. Nitrofuryl-substituted 3-amino-1,2,4-oxadiazoles and 5-amino-1,2,4-oxadiazoles. J. Med. Chem., 1969, 12, 708-709.
71. Durden, J.A.; Heywood, Jr. D.L. The Acylation of Benzamidoximes. J. Org. Chem., 1965, 30, 4359.
72. Young, T. E.; Beidler, W. T. Direct synthesis of 5-methyl-3-aryl-1,2,4-oxadiazoles from aryl aldehydes, nitroethane, and ammonium acetate. J. Org. Chem., 1985, 50, 1182.
73. Liang Gui-Bal.; Qian, X. Oxidiazole synthesis on solid supports. Bioorg. Med. Chem. Lett., 1999, 9, 2101.
74. Young, J. R.; DeVita, R. J. Novel synthesis of oxadiazoles via palladium catalysis. Tetahedron. Lett., 1998, 39, 3931-3934.
75. Gangloff, A. R.; Litvak, J.; Shelton, E.; Sperandio, D.; Wang, V.R.; Rice, K. D. Synthesis of 3,5-disubstituted-1,2,4-oxadiazoles using tetrabutylammonium fluoride as a mild and efficient catalyst. Tetahedron Lett., 2001, 42, 1441-1443.
76. Katritzky, A. R.; Shestopalov, A. A. A convenient synthesis of chiral 1,2,4-oxadiazoles from N-protected (α-aminoacyl) benzotriazoles. ARKIVOC 7, 2005, 36-55.
77. Yarovenko, V. N.; Kosarev, S. A. Synthesis of 3_carbamoyl_ 1,2,4_oxadiazoles Russian Chem. Bull., 2002, 51, 1857-61.
78. Deegan Tracy L.; Nitz, T. J.; Cebzanov, D.; Pufko, D. E.; Porco, J.A. Parallel synthesis of 1,2,4-oxadiazoles using CDI activation. Bioorg. Med. Chem. Lett., 1999, 9, 209-212.
79. Braga, A.L.; Lokdte, D.S. 'One-Pot' Synthesis of Chiral N-Protected α-Amino Acid-Derived 1,2,4-Oxadiazoles. Synthesis, 2004, 1589-1591.
80. Caddick, S. Microwave-assisted Organic-reactions. Tetrahedron, 1995, 51, 10403-10432.
81. Kaboudin, B.; Saadati, F. Novel method for the synthesis of 1,2,4-oxadiazoles using alumina supported ammonium fluoride under solvent-free condition. J. Heterocycl. Chem., 2005, 42, 699-706.
82. V. Santagada; Frecentese, F.; Perissutti E.; Cirillo, D.; Terracciano S.; Caliendo G. A suitable 1,2,4-oxadiazoles synthesis by microwave irradiation. Bioorg. Med. Chem. Lett., 2004, 14, 4491-4493.
83. Evans, M. D.; Ring, Adam S; Andrew, B.; Paul, E.; Didier, B.; Robb, N.; Carmen, M. B. The accelerated development of an optimized synthesis of 1,2,4-oxadiazoles: application of microwave irradiation and statistical design of experiments. Tetrahedron Lett., 2003, 44, 9337-9340.
84. Rostamizadeh, S.; Housaini, S. A. G. Microwave assisted syntheses of 2,5-disubstituted 1,3,4-oxadiazoles Tetahedron Lett., 2004, 45, 8753-8755.
85. Villemin, D.; Caillot, F. Microwave mediated palladium-catalysed reactions on potassium fluoride/alumina without use of solvent. Tetahedron Lett., 2001, 42, 639-642.
86. Adib, M.; Jahromi, A. H. Microwave-assisted efficient, one-pot, three-component synthesis of 3,5-disubstituted 1,2,4-oxadiazoles under solvent-free conditions. Tetahedron Lett., 2006, 47, 2965-2969.
87. Ricardo, A. W.; Srivastava, R. M. A Handy and Solventless Direct Route to Primary 3-[3-Aryl)-1,2,4-oxadiazol-5-yl]propionamides Using Microwave Irradiation. Molecules, 2006, 11, 318-321.
88. Leallyn, B.C. 1, 2, 4-Oxadiazoles. Adv. Heter. Chem., 1976, 20, 65-116.
89. Watthey, J. W. H.; Desai, M.; Rutledge, R.; Dotson, R. Synthesis and diuretic profile of 3-(3-amino-1,2,4-oxadiazol-5-yl)-5-chloro-2,6-pyrazinediamine, an amiloride-type diuretic. J. Med. Chem., 1980, 23, 690-699.
90. Swinbourne, F.J.; Hunt, J.H.; Klinkert G. Advances in Indolizine Chemistry. Adv. Heter. Chem., 1979, 23, 103-170.
91. Eloy, F.; Lenaers, R. The Chemistry of Amidoximes and Related Compounds. Chem. Rev., 1962, 62, 155-183.
92. Ying, W.; Reagan, L.; Miller, Daryl R. S.; Stevan, W. D. Rapid and Efficient Synthesis of 1,2,4-Oxadiazoles Utilizing Polymer-Supported Reagents under Microwave Heating. Org. Lett., 2005, 7, 925-928.
93. Haugwitz, R.D.; Maurer, B.V.; Jacobs, G.A.; Narayanan, V.L.; Cruthers, L.; Szanto, J. Antiparasitic agents. 3. Synthesis and anthelmintic ac tiv itie s of novel 2-pyridinyl-5-isothiocyanatobenzimidazoles. J. Med. Chem. 1979, 22, 1113-1118.
94. Boykin, D. W. Antimicrobial Activity of the DNA Minor Groove Binders Furamidine and Analogs. J. Braz. Chem. Soc., 2002, 13, 763-767.
95. Boykin, D. W. Anti-pneumocystis activity of bis-amidoximes and bis-o-alkylamidoximes prodrugs. Bioorg. Med. Chem. Lett., 1996, 6, 3017-3020.
96. Francesconi, I.; Wilson, W. D.; Tanious, F. A.; Hall, J. E.; Bender, B. C.; Tidwell, R. R.; McCurdy, D.; Boykin, D. W. Dicationic diarylfurans as anti-Pneumocystis carinii agents. J. Med. Chem., 1999, 42, 2260-2264.
97. Fox, K. R.; Sansom, C. E. Footprinting studies on the sequence-selective binding of pentamidine to DNA FEBS Lett., 1990, 266, 150-155.
98. Brown, D. G.; Sanderson, M. R. Crystal structure of a berenil-d(CGCAAATTTGCG) complex. An example of drug-DNA recognition based on sequence-dependent structural features. J. Mol. Biol., 1992, 226, 481-487.
99. Greenhill, J. V.; Lue, P. Amidines and guanidines in medicinal chemistry. Prog. Med. Chem., 1993, 30, 203-326.
100. Apted, F.I.C. Present status of chemotherapy and chemopropylaxis of human trypanosomiasis in the Eastern Hemisphere. Pharmacol. Ther., 1980, 11, 391-399.
101. Bryceson, A. D.; Chulay, J. D. Visceral leishmaniasis unresponsive to antimonial drugs. II. Response to high dosage sodium stibogluconate or prolonged treatment with pentamidine. Trans. Roy. Soc. Trop. Med. Hyg., 1985, 79, 705-714.
102. Hughes, W.T.; McNabb, P. C. Efficacy of trimethoprim and sulfamethoxazole in the prevention and treatment of Pneumocystis carinii pneumonitis. Antimicrob. Agents. Chemother., 1974, 5, 289-293.
103. Ismail, M.A.; Brun, R.; Easterbrook, J.; Boykin, D. Synthesis and antiprotozoal activity of aza-analogues of furamidine. J. Med. Chem., 2003, 46, 4761-4769.
104. Das B. P.; Boykin D. W. Synthesis and antiprotozoal activity of 2,5-bis(4-guanylphenyl)thiophenes and -pyrroles. J. Med. Chem., 1977, 20, 1219-1221.
105. Ismail, M. A.; Arafa, R. K.; Brun, R.; Wenzler, T.; Miao, Y.; Wilson, W. D.; Generaux, C.; Bridges, A.; Hall, J. E.; Boykin, D. W. Synthesis, DNA affinity, and antiprotozoal activity of linear dications: Terphenyl diamidines and analogues. J. Med. Chem., 2006, 49, 5324-5332.
106. Das B. P.; Wallace R. A.; Boykin D. W. Synthesis and antitrypanosomal activity of some bis(4-guanylphenyl) five- and six-membered ring heterocycles. J. Med.Chem., 1980, 23, 578-581.
107. Cottrell, D. M.; Capers, J.; Salem, M. M.; Croft, S. L.; Werbovetz, K. A. Antikinetoplastid activity of 3-aryl-5-thiocyanatomethyl-1,2,4-oxadiazoles. Bioorg. Med. Chem. Lett., 2004, 12, 2815-2824.
108. Weidner-Wells, M. A.; Henninger, T. C.; Fraga-Spano, S. A.; Boggs, C. M.; Matheis, M.; Ritchie, D. M.; Argentieri, D. C.; Wachter, M. P.; Hlasta, D. J. Synthesis and structure-activity relationships of 3, 5- diarylisoxazoles and 3, 5-diaryl-1, 2, 4-oxadiazoles, novel classes of sma ll mo lec u le in te rleu kin-8 (IL-8) rece ptor an tag on ists. Bioo rg. Med. Chem. Lett., 2004, 14, 4307-4311.
109. Palazzo, G. M.; Tavella, M.; Strani, G.; Silvestrini, B. Synthesis and Pharmacological Properties of a Series of Substituted Aminoalkyl-1, 2, 4-oxadiazoles. J. Med. And Pharma. Chem., 1961, 4, 351-357.
110. Tiemann, F.; Kruger, P. Ueber Amidoxime und Azoxime. Chem. Ber., 1884, 17, 1685-1692.
111. Domenjoz, R. Zur Auswertung hustenstillender Arznei- mittel. Arch. Exp. Path. Pharmakol., 1952, 215, 19-23.
112. Randall, L. O.; Selitto, J. J. A method for measurement of analgesic activity on inflamed tissue.Arch. Int. Pharmacodyn., 1957, 111, 409-419.
113. Unangst, P. C.; Shrum, G. P.; Connor, D. T.; Dyer, R. D.; Schrier, D. J. Novel 1,2,4-oxadiazoles and 1,2,4-thiadiazoles as dual 5- lipoxygenase and cyclooxygenase inhibitors, J. Med. Chem., 1992, 35, 3691-3696.
114. Nicolaides, D. N.; Fylatakidou, K. C. Synthesis and biological evaluation of several coumarin-4-carboxamide and 3-(coumarin-4-yl)-1, 2, 4-oxadiazole derivatives Eur. J. Med. Chem., 1998, 33,715-720.
115. Sterne, J.; Pele, M. F.; Hirsch, C. Pharmacological effect of phenyl-3-dibutylaminoethylamino-5 oxadiazole 1,2,4 (LA 1221), particularly on the peripheral vessels Fr. Therapie., 1969, 24, 735-742.
116. Gezginci, M. H.; Martin, A. R.; Franzblau, S. G. Antimycobacterial activity of substituted isosteres of pyridine- and pyrazinecarboxylic acids. 2 J. Med. Chem., 2001, 44, 1560-1567.
117. Daunta, Pancechowska-Ksepko; Henryk, F.; Mieczyslaw, J.; Zofia, Z. Synthesis and antibacterial activity of 1H-pyrazolo[3,4-b]pyrazine and -pyridine derivatives. Acta Poloniae Phamaceutica., 1986, 43, 211-215.
118. Ernst, D. B.; Bendas, H.; D'Avilla, Uriel. New substances of possible chemotherapeutical value. I, J. Org. Chem., 1953, 18, 64-67.
119. Diana, G. D.; Volkots, D. L.; Nitz, T. J.; Bailey, T. R.; Long, M. A; Vescio, N.; Aldous, S.; Pevear, D. C.; Dutko, F. J. Oxadiazoles as ester bioisosteric replacements in compounds related to disoxaril. Antirhinovirus activity J. Med. Chem., 1994, 37, 2421-2436.
120. Zhang, H. Z.; Kasibhatla, S.; Kuemmerle, J.; Kemnitzer, W.; Ollis-Mason, K.; Qiu, L.; Crogan-Grundy, C.; Tseng, B.; Drewe, J.; Cai, S. X. Discovery and structure-activity relationship of 3-aryl-5-aryl-1,2,4-oxadiazoles as a new series of apoptosis inducers and potential anticancer agents. J. Med. Chem., 2005, 48, 5215-5223.
121. Hennen, W. J.; Robins, R. K. Synthesis of 5-(β-D-ribofuranosyl)-1,2,4-oxadiazole-3-carboxamide. J. Heterocycl. Chem., 1985, 22, 1747-1750.
122. Witkowski, J. T.; Robins, R. K.; Sidwell, R. W.; Simon, L. N. Design, synthesis, and broad spectrum antiviral activity of 1- -D-ribofuranosyl-1,2,4-triazole-3-carboxamide and related nucleosides. J. Med. Chem., 1972, 15, 1150-1154.
123. Srivastava, P. C.; Pickering, M. V.; Allen, L. B.; Streeter, D. G.; Campbell, M. T.; Witkowski, J. T.; Sidwell, R. W.; Robins, R. K. Synthesis and antiviral activity of certain thiazole C-nucleosides J. Med. Chem., 1977, 20, 256-262.
124. Chih-Shiang, C.; Wai Ming, K. Design and Synthesis of 1,2,4-Oxadiazole Derivatives as Non-steroidal 5a-Reductase Inhibitors J. Chinese Chem. Soc., 2002, 49, 83-89.
125. Mylari, B. L.; Beyer, T. A.; Scott, P. J.; Aldinger, Charles E.; Dee, M. F.; Siegel, T. W.; Zembrowski, W. J. Potent, orally active aldose reductase inhibitors related to zopolrestat: surrogates for benzothiazole side chain, J. Med. Chem., 1992, 35, 457-465.
126. Watjen, F.; Baker, R.; Engelstoff, M.; Herbert, R.; MacLeod, A.; Knight, A.; Merchant, K.; Moseley, J.; Saunders, J. Novel benzodiazepine receptor partial agonists: oxadiazolylimida-zobenzodiazepines J. Med. Chem., 1989, 32, 2282-2291.
127. Andersen, K.E.; Lundt, B.F. Oxadiazoles as bioisosteric transformations of carboxylic functionalities. II. Eur. J. Med. Chem., 1996, 31, 417-425.
128. Cavalleri, B.; Volpe, G.; Del Turco, B.R.; Diena, A. II Farmaco, edi. Scientific, 1976, 31(6), 393-402.
129. Chen, Cheng-yi.; Senanayake, C.H.; Bill, T.J.; Larsen, R.D.; Verhoeven, T R.; Reider, P.J. J. Org. Chem., 1994, 59, 3738-3741.
130. Macor, J. E.; Ordway, T.; Smith, R. L.; Verhoest, P. R.; Mack, R. A. J. Org. Chem., 1996, 61, 3228-3229.
131. Vu, C. B.; Corpuz, E. G.; Merry, T. J.; Pradeepan, S. G.; Bartlett, C.; Bohacek, R. S.; Botfield, M. C.; Eyermann, C. J.; Lynch, B. A.; MacNeil, I. A.; Ram, M. K.; van Schravendijk, M. R.; Violette, S.; Sawyer, T. K. Discovery of potent and selective SH2 inhibitors of the tyrosine kinase ZAP-70. J. Med. Chem., 1999, 42, 4088-4098.
132. Bedford, C. D.; Howd, R. A.; Dailey, O. D.; Miller, A.; Nolen, H.W.; Kenley, R. A.; Kern, J. R.; Winterle, J. S. Nonquaternary cholinesterase reactivators. 3. 3(5)-Substituted 1,2,4-oxadiazol-5(3)-aldoximes and 1,2,4-oxadiazole-5(3)-thiocarbohydroximates as reactivators of organophosphonate-inhibited eel and human acetylcholinesterase in vitro J. Med. Chem., 1986, 29, 2174-2183.
133. Saunders, J.; Cassidy, M.; Freedman, S. B.; Harley, E. A.; Iversen, L. L.; Kneen, C.; MacLeod, A. M.; Merchant, K. J.; Snow, R. J.; Baker R. Novel quinuclidine-based ligands for the muscarinic cholinergic receptor. J. Med. Chem., 1990, 33, 1128-1138.
134. Li, Z.; Chen, W.; Hale, J. J.; Lynch, C. L.; Mills, S. G.; Hajdu, R.; Keohane, C. A.; Rosenbach, M. J.; Milligan, J. A.; Shei, G.-J.; Chrebet, G.; Parent, S. A.; Bergstrom, J.; Card, D.; Forrest, M.; Quackenbush, E. J.; Wickham, L. A.; Vargas, H.; Evans, R. M.; Rosen, H.; Mandala, S. Discovery of Potent 3,5-Diphenyl-1,2,4-oxadiazole Sphingosine-1-phosphate-1 (S1P1) Receptor Agonists with Exceptional Selectivity against S1P2 and S1P3. J. Med. Chem., 2005, 48, 6169-6173.
135. Bock, M. G.; Smith, R. L.; Blaine, E. H.; Cragoe, E. J. Synthesis and biological activity of 3-amino-5-(3,5-diamino-6-chloropyrazin-2-yl)-1,2,4-oxadiazole: an amiloride prodrug J. Med. Chem., 1986, 29, 1540-1544.
136. Schapel, G.J.; Edwards, K.D. Potassium-sparing effect of amiloride in a diuretic factorial study in man J. Clin. Exp. Pharmacol. Physiol., 1975, 2, 277-287.
137. Santilli, A. A.; Morris, R. L. Synthesis of 3-arylsulfonylmethyl-1,2,4-oxadiazole-5-carboxylic acid derivatives J. Heterocycl. Chem., 1979, 16, 1197-1200.
138. Lloyd, J.; Schmidt, J. B.; Rovnyak, G.; Ahmad, S.; Atwal, K. S.; Bisaha, S.N.; Doweyko, L.M.; Stein, P.D.; Traeger, S.C.; Mathur, A.; Conder, M.L.; DiMarco, J.; Harper, T.W.; Jenkins- West, T.; Levesque, P. C.; Normandin, D.E.; Russell, A.D.; Serafino, R.P.; Smith, M.A.; Lodge, N.J. Design and synthesis of 4-substituted benzamides as potent, selective, and orally bioavailable I(Ks) blockers J. Med. Chem., 2001, 44, 3764-3767.
139. Elzein, E.; Prabha, I.; Dmitry O.K.; Ken, R.; Shenk, K. D.; Timothy, M. A.; Bob, Jiang; Li, Xiaofen; Natero, R.; Li Y.; Nguyen, M.; Kerwar, S.; Chu, N.; Soohoo, D.; Hao, J.; Maydanik, V. Y.; Lustig, D. A.; Zeng, D.; Leung, K.; Zablocki, J. A. CVT-4325: a potent fatty acid oxidation inhibitor with favorable oral bioavailability. Bioorg. Med. Chem. Lett., 2004, 14, 6017-6021.
140. Emerson, M.; Antonio, J. C.; Gallardo, H. Synthesis of New 1,2,4-and 1,3,4-Oxadiazole Derivatives. Synthesis, 2003, 6, 899-907.
141. Brizzi V, Brufani M, Filocamo L, Bruni G, Fiaschi AI. New 1,2,4-oxadiazole derivatives: synthesis and adrenergic receptors binding studies. Farmaco., 1992, 47(6), 953-66.
142. Palmer, J. T.; Rydzewski, R. M.; Mendonca, R. V.; Sperandio, D.; Spencer, J. R.; Hirschbein, B. L.; Lohman, J.; Beltman, J.; Nguyen, M.; Liu, L. Design and synthesis of selective keto-1,2,4-oxadiazole-based tryptase inhibitors. Bioorg. Med. Chem. Lett., 2006, 16, 3434-3439.
143. Kraemer, I.; Walter, S. Synthesis and H2-antagonistic activity of N3,N5-substituted 1,2,4-oxadiazole-3,5-diamines Arzneim-Forsch., 1986, 36, 1011-1014.
144. Yurigi, S.; Miyake, A.; Tominoto, M.; Matsumura, H.; Imai, Y. Syntheses of N-heterocyclic compounds. IV. Hypocholesterolemic 1,2,4-oxadiazole derivatives. Chem. Pharm. Bull., 1973, 21, 1885-1893.
145. Bethge, K.; Pertz, H. H.; Rehse, K. New Oxadiazole Derivatives Showing partly Antiplatelet, Antithrombotic and Serotonin Antagonistic Properties Archiv der Pharmazie, 2005, 338, 78-86.
146. European Medicines Agency Pre-authorisation Evaluation of Medicines for Human use orphandrugs@emea.europa.eu, www.emea.europa.euEMEA2007Doc.Ref.:EMEA/COMP/122996/2005 Rev.2
147. Florea, N.; Maglio, D.; Nicolau, D. Pharmacotherapy. J. Hum. Pharma. Drug Therap., 2003, 23, 339-348.
148. Carroll, F. I.; Gray, J. L.; Abraham, P.; Kuzemko, M. A.; Lewin, A. H.; Boja, J. W.; Kuhar, M. J. 3-Aryl-2-(3'-substituted-1',2',4'-oxadiazol-5'-yl)tropane analogues of cocaine: affinities at the cocaine binding site at the dopamine, serotonin, and norepinephrine transporters. J. Med. Chem., 1993, 36, 2886-2890.
149. Tang, A. H.; Franklin, S. R.; Himes, C. S.; Ho, P. M. Behavioral effects of U-78875, a quinoxalinone anxiolytic with potent benzodiazepine antagonist activity. J. Pharmacol. Exp. Ther., 1991, 259, 248-254.
150. Ulrich, R. G.; Bacon, J. A.; Brass, E. P.; Cramer, C. T.; Petrella, D. K.; Sun, E. L. Metabolic, idiosyncratic toxicity of drugs: overview of the hepatic toxicity induced by the anxiolytic, panadiplon. Chem. Biol. Interact., 2001, 134, 251-270.
151. Platt, D. M.; Duggan, A.; Spealman, R. D.; Cook, J. M.; Li, X.; Yin, W.; Rowlett, J. K. Contribution of alpha 1GABAA and alpha 5GABAA receptor subtypes to the discriminative stimulus effects of ethanol in squirrel monkeys. J. Pharmacol. Exp. Ther., 2005, 313, 658-667.
152. Van, D. J.; Gerven, J. M.; Schoemaker, R. C.; Roncari, G.; Oberyé, J. J. Integrated pharmacokinetics and pharmacodynamics of Ro 48-6791, a new benzodiazepine, in comparison with midazolam during first administration to healthy male subjects Br. J. Clin. Pharmacol., 1997, 44, 477-486.
153. Tang, J.; Wang, B., White, P. F.; Gold, M. Comparison of the sedation and recovery profiles of Ro 48-6791, a new benzodiazepine, and midazolam in combination with meperidine for outpatient endoscopic procedures. Anesthesia and Analgesia, 1999, 89, 893-898.
154. Gold, M. E.; Todd, S. A.; Spiegler, C. When the drug trial fails: an approach to clinical drug studies. AANA J., 1999, 67, 505-512.
155. Ihmsen, H.; Albrecht, S.; Hering, W.; Schüttler, J.; Schwilden, H. Modelling acute tolerance to the EEG effect of two benzodiazepines. Br. J. Clin. Pharmacol., 2004, 57, 153-161.
156. Jacobsen, E.J.; TenBrink, R.E.; Stelzer, L.S.; Belonga, K.L.; Carter, D.B.; Im, H.K.; Im, W. B.; Sethy, V.H.; Tang, A.H.; VonVoigtlander, P.F.; Petke, J.D.; High-affinity partial agonist imidazo[1,5-a]quinoxaline amides, carbamates, and ureas at the gamma-aminobutyric acid A/benzodiazepine receptor complex. J. Med. Chem., 1996, 39(1), 158-75.
157. Clitherow, J.W.; Beswick, P.; Irring, W.J. Novel 1,2,4-oxadiazoles as potent and selective histamine H3receptor antagonists. Bioorg. Med. Chem. Lett., 1996, 6, 833-838.
158. Olesen, P.H.; Tonder, J. E.; Hansen, J. B. Bioisosteric replacement strategy for the synthesis of 1-azacyclic compounds with high affinity for the central nicotinic cholinergic receptors. Bioorg. Med. Chem. Lett., 2000, 8, 1443-1450.